NASDAQ
SCPH

Scpharmaceuticals Inc

Biotechnology
Healthcare

Prices are adjusted according to historical splits.

Scpharmaceuticals Inc Stock Price

Vitals

Today's Low:
$7.13
Today's High:
$7.6746
Open Price:
$7.58
52W Low:
$3.68
52W High:
$12.75
Prev. Close:
$7.59
Volume:
189949

Company Statistics

Market Cap.:
$272.15 million
Book Value:
1.769
Revenue TTM:
$3.70 million
Operating Margin TTM:
-1210.38%
Gross Profit TTM:
$0
Profit Margin:
0%
Return on Assets TTM:
-32.31%
Return on Equity TTM:
-86.2%

Company Profile

Scpharmaceuticals Inc had its IPO on 2017-11-17 under the ticker symbol SCPH.

The company operates in the Healthcare sector and Biotechnology industry. Scpharmaceuticals Inc has a staff strength of 96 employees.

Stock update

Shares of Scpharmaceuticals Inc opened at $7.58 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $7.13 - $7.67, and closed at $7.16.

This is a -5.67% slip from the previous day's closing price.

A total volume of 189,949 shares were traded at the close of the day’s session.

In the last one week, shares of Scpharmaceuticals Inc have slipped by -4.15%.

Scpharmaceuticals Inc's Key Ratios

Scpharmaceuticals Inc has a market cap of $272.15 million, indicating a price to book ratio of 7.4873 and a price to sales ratio of 0.

In the last 12-months Scpharmaceuticals Inc’s revenue was $3.70 million with a gross profit of $0 and an EBITDA of $-44765000. The EBITDA ratio measures Scpharmaceuticals Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Scpharmaceuticals Inc’s operating margin was -1210.38% while its return on assets stood at -32.31% with a return of equity of -86.2%.

In Q2, Scpharmaceuticals Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Scpharmaceuticals Inc’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $-1.38 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Scpharmaceuticals Inc’s profitability.

Scpharmaceuticals Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -6.1053. Its price to sales ratio in the trailing 12-months stood at 0.

Scpharmaceuticals Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$114.17 million
Total Liabilities
$6.64 million
Operating Cash Flow
$0
Capital Expenditure
$3000
Dividend Payout Ratio
0%

Scpharmaceuticals Inc ended 2024 with $114.17 million in total assets and $0 in total liabilities. Its intangible assets were valued at $114.17 million while shareholder equity stood at $-251900000.00.

Scpharmaceuticals Inc ended 2024 with $0 in deferred long-term liabilities, $6.64 million in other current liabilities, 4000.00 in common stock, $-251900000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $71.35 million and cash and short-term investments were $102.88 million. The company’s total short-term debt was $267,000 while long-term debt stood at $37.74 million.

Scpharmaceuticals Inc’s total current assets stands at $113.57 million while long-term investments were $0 and short-term investments were $31.53 million. Its net receivables were $1.61 million compared to accounts payable of $1.18 million and inventory worth $5.83 million.

In 2024, Scpharmaceuticals Inc's operating cash flow was $0 while its capital expenditure stood at $3000.

Comparatively, Scpharmaceuticals Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$7.16
52-Week High
$12.75
52-Week Low
$3.68
Analyst Target Price
$19.2

Scpharmaceuticals Inc stock is currently trading at $7.16 per share. It touched a 52-week high of $12.75 and a 52-week low of $12.75. Analysts tracking the stock have a 12-month average target price of $19.2.

Its 50-day moving average was $8.08 and 200-day moving average was $8.4 The short ratio stood at 21.36 indicating a short percent outstanding of 0%.

Around 660.4% of the company’s stock are held by insiders while 7558.4% are held by institutions.

Frequently Asked Questions About Scpharmaceuticals Inc

The stock symbol (also called stock or share ticker) of Scpharmaceuticals Inc is SCPH

The IPO of Scpharmaceuticals Inc took place on 2017-11-17

Similar Industry Stocks (Biotechnology)

Last Price
Chg
Chg%
$4.49
-0.05
-1.1%
$220.4
5.51
+2.56%
$18.55
0.07
+0.38%
$0.14
-0.01
-6.67%
Oracle Credit Ltd (ORACLECR)
$147.45
-2.75
-1.83%
$10.35
0
0%
$0.58
-0.01
-1.37%
$22.58
-0.19
-0.83%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company’s lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. The company was incorporated in 2013 and is headquartered in Burlington, Massachusetts.

Address

2400 District Avenue, Burlington, MA, United States, 01803